Comparison of Pegfilgrastim Prescribing Practice to National Guidelines at a University Hospital Outpatient Oncology Clinic

PURPOSE: Pegfilgrastim reduces the risk of febrile neutropenia (FN) and is indicated as primary prophylaxis when the risk of FN approaches 20% in each chemotherapy cycle. There have been few reports evaluating the appropriate use of pegfilgrastim in comparison with published guidelines. We sought to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Waters, Geralyn E., Corrigan, Patricia, Gatesman, Mandy, Smith, Thomas J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2013
Konular:
Focus on Quality
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3710170/
https://ncbi.nlm.nih.gov/pubmed/23942922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2012.000662
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller